Comparison of Two Methods for Concentrating CD34 + Cells from Patients with Acute Non-Lymphocytic Leukemia

References

• Silvestri F., Banavali S., Baccarani M., Preisler H. D. The CD34 hemopoietic progenitor cell associated antigen biology and clinical applications. Haematologica 1992; 77: 265–272
   PubMed Web of Science ®Google Scholar
• Civin C. I., Strauss L. C., Brovall C., Fackler M. J., Schwartz J. F., Shaper J. H. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J. Immunol. 1984; 1: 157–165
   Google Scholar
• Tindle R. W., Nichols R. A. B., Chan L., Campana D., Catovsky D., Birnie G. D. A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk. Rex 1985; 9: 1–9
   PubMed Web of Science ®Google Scholar
• Batinic D., Tindle R., Boban D., Tiefenbach A., Rajic L., Labar B., Nemet D., Boranic M. Expression of hematopoietic progenitor cell-associated antigen BI-3C5/CD34 in leukaemia. Leuk. Res 1989; 13: 83–85
   PubMed Web of Science ®Google Scholar
• Berenson R. J., Andrews R. G., Bensinger W. I., Kalamasz D. F., Hill R. S., Still B. J., Weiden P., Shulman H. M., Warnke R., Buckner C. D., Bernstein I. D., Dicke K. A., Spitzer G., Jagannath S., Evinger-Hodges M. J. Selection of CD34+ marrow cells for autologous marrow transplantation. Autologous bone marrow transplantation. Proceedings of the fourth International Symposium. Texas, P, Huston 1989; 55–60, The University of Texas and MD Anderson Cancer Center Publishers.
   Google Scholar
• Campos L., Guyotat D., Archimbaud E., Devaux Y., Treille D., Larese A., Maupas J., Gentilhomme D., Ehrsam A., Fiere D. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. Brit. J. Haemutol. 1989; 72: 161–166
   PubMed Web of Science ®Google Scholar
• Matutes E., Rodriguez B., Polli N., De Castro J. T., Parreira A., Andrews C., Griffin J. D., Tindle R. W., Catovsky D. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9. Hemat. Oncol. 1985; 3: 179–186
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Gockerman J. P., Moore J. O., Civin C. I., Page S. O., Robertson J., Binger S. H. Clinicopathologic and cytogenetic features of CD34 (My10)-positive acute nonlymphocytic leukemia. Am. J. Clin. Pathol. 1989; 91: 265–270
   PubMed Web of Science ®Google Scholar
• Geller R. B., Zahurak M., Hurwitz C. A., Burke P. J., Karp J. E., Piantadosi S., Civin C. L. Prognostic importance of immunophenotyping in adults with acute myelocytic leukemia: the significance of the stem-cell glycoprotein CD34 (My10). Brit. J. Haematol. 1990; 7: 340–347, 6
   Web of Science ®Google Scholar
• Vaughan W. P., Civin C. I., Weisenburger D. D., Karp S. E., Graham K. L., Sanger W. G., Grierson H. L., Joshi S. S., Burke P. J. Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MylO). Leukemia 1989; 2: 661–666
   Web of Science ®Google Scholar
• Lee E. J., Yang J., Civin C. I., Schiffer C. A. The impact of TdT and CD34 expression on the prognosis of patients with acute myeloid leukemia. Blood 1989; 74(suppl. 1)18a
   Google Scholar
• Silvestri F., Banavali S., Yin M., Hulette B., Gopal V., Civin C. I., Baccarani M., Preisler H. D. CD34 antigen expression of acute myeloid leukemia-colony forming cells. Int. J. Cell Cloning 1992; 10(suppl. 1)98–100
   Google Scholar
• Yin M., Silvestri F., Banavali S., Gopal V., Hulette B., Kuvelkar R., Young A., Mayers G., Preisler H. D. Clonogenic potential in vitro is restricted to myeloid leukemia cells expressing the CD34 antigen. Eur. J. Cancer 1992, in press.
   Web of Science ®Google Scholar
• Passano S., Palumbo A., Ferrero D., Pagliari G. L., Bottero L., Lai S. K., Meo P., Carter C., Hubbell H., Lange B., Rovera G. Subpopulation heterogeneity in human acute myeloid leukemia determined by monoclonal antibodies. Blood 1984; 64: 275–281
   PubMed Web of Science ®Google Scholar
• Wouters R, Löwenberg B. On the maturation order of AML cells: a distinction on the basis of self-renewal properties and immunologic phenotypes. Blood 1984; 63: 684–689
   PubMed Web of Science ®Google Scholar
• Sabbath K. D., Ball E. D., Larcom P., Davis R. B., Griffin J. D. Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J. Clin. Invest. 1985; 75: 746–753
   PubMed Web of Science ®Google Scholar
• Löwenberg B., Bauman G. J. Further results in understanding the subpopulation structure of AML: clonogenic cells and their progeny identified by differentiation markers. Blood 1985; 66: 1225–1232
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Löwenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood 1986; 68: 1185–1195
   PubMed Web of Science ®Google Scholar
• Vellenga E., Young D. C., Wagner K., Wiper D., Ostapovicz D., Griffin J. D. The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 1987; 69: 1771–1776
   PubMed Web of Science ®Google Scholar
• Delwel R., Dorssers L., Touw I., Wagemaker G., Löwenberg B. Human recombinant multilineage colony stimulating factor (interleukin-3): stimulating of acute myelocytic leukemia progenitor cells in vitro. Blood 1987; 70: 333–336
   PubMed Web of Science ®Google Scholar
• Delwel R., Van Gurp R., Bot F., Touw I., Löwenberg B. Phenotyping of acute myelocytic leukemia (AML) progenitors: an approach for tracing minimal numbers of AML cells among normal bone marrow. Leukemiu 1988; 12: 814–819
   Google Scholar
• Delwel R., Salem M., Pellens C., Dorssers L., Wagemaker G., Clark S., Löwenberg B. Growth regulation of human acute myeloid leukemia: effects of five recombinant hematopoietic factors in a serum-free culture system. Blood 1988; 72: 1944–1949
   PubMed Web of Science ®Google Scholar
• Motoji T., Takanashi M., Fuchinoue M., Masuda M., Oshimi K., Mizoguchi H. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia. Exp. Hematol. 1989; 17: 56–60
   PubMed Web of Science ®Google Scholar
• Lemoli R. M., Gulati S. C., Strife A., Lambek C., Perez A., Clarkson B. D. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Leukemia 1991; 5: 386–391
   PubMed Web of Science ®Google Scholar
• Civin C. I., Strauss L. C., Fackler M. J., Trischmann T. M., Wiley J. M., Loken M. R. Positive stem cell selection—basic science. Bone Marrow purging and processing, S. Gross, A. Gee, D. Worthington-White. Whiley-Liss Publishers, New York 1990; 387–402, PP: 387–402.
   Google Scholar
• Wysocki L. J., Sat V. L. “Panning” for lymphocytes: a method for cell selection. Proc. Natl. Acad. Sci. 1978; 75: 2844–2848
   PubMed Web of Science ®Google Scholar
• Greenberg P. L., Baker S., Link M., Monowada J. Immunologic selection of hemopoietic precursor cells utilizing antibody-mediated plate binding (“Panning”). Blood 1985; 65: 190–197
   PubMed Web of Science ®Google Scholar
• Strauss L. C., Rowley S. D., La Russa V. F., Sharkis S. J., Stuart R., Civin C. I. Antigen analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp. Hematol. 1986; 14: 878–886
   PubMed Web of Science ®Google Scholar
• Saeland S., Caux C., Favre C., Aubry J. P., Mannoni P., Pebusque M. J., Gentilhomme O., Otsuka T., Yokota T., Arai N., Arai K., Banchereau J., De Vries J. E. Effects of recombinant human interleukin-3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells. Blood 1988; 72: 1580–1588
   PubMed Web of Science ®Google Scholar
• Takaue Y., Kawano Y., Reading C. L., Watanabe T., Abe T., Ninomiya T., Shimizu E., Ogura T., Kuroda Y., Yokobayashi A., Nakahata T., Asano S., Ventura G. Effects of recombinant human G-CSF, GM-CSF, IL-3 and IL-l on the growth of purified human peripheral blood progenitors. Blood 1990; 76: 330–335
   PubMed Web of Science ®Google Scholar
• Carlo-Stella C., Mangoni L., Almici C., Frassoni F., Fiers W., Rizzoli V. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors. Leukemia 1990; 4: 561–566
   PubMed Web of Science ®Google Scholar
• Gore S. D., Kastan M. B., Civin C. I. Normal human bone marrow precursors that express terminal deoxynucleoti-dyl transferase include T-cell precursors and possible lymphoid stem cells. Blood 1991; 77: 1681–1690
   PubMed Web of Science ®Google Scholar
• Silvestri F., Banavali S. D., Hulette B. C., Civin C. I., Preisler H. D. Isolation and charactcrization of the CD34+ hematopoietic progenitor cells from the peripheral blood of patients with chronic myeloid leukemia. Inr. J. Cell Clon. 1991; 9: 474–490
   PubMedGoogle Scholar
• Strauss L. C., Trischmann T. M., Rowley S. D., Wiley J. M., Civin C. I. Selection of normal human hematopoietic stem cells for hone marrow transplantation using immunomagnetic mircospheres and CD34 antibody. Am. J. Pediatr. Hiematol. Oncol. 1991; 13: 217–221
   Web of Science ®Google Scholar